Literature DB >> 30294993

Investigating the child with intellectual disability.

David J Amor1,2.   

Abstract

The search for causation is a key component of the assessment of the child with intellectual disability. Historically, a specific diagnosis has been achievable in only a small minority of these children, but over the last decade, this has changed dramatically such that a specific diagnosis is now possible in about half of all children with intellectual disability. This improvement has been driven by major advances in genetic-testing technologies, the most important of which are chromosome microarray and whole exome sequencing. Simultaneously, these technological advances have revealed many new genetic syndromes that had previously escaped clinical recognition, and demonstrated that the majority of severe intellectual disability is caused by pathogenic gene variants that arise de novo in the child. Although access to genomic testing is currently limited, evidence from health economic studies suggests that this testing is most cost effective when performed early in the patient's diagnostic journey.
© 2018 Paediatrics and Child Health Division (The Royal Australasian College of Physicians).

Entities:  

Keywords:  chromosome microarray; fragile X testing; genetic diagnosis; intellectual disability; urine metabolic screening

Mesh:

Year:  2018        PMID: 30294993     DOI: 10.1111/jpc.14202

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  4 in total

1.  Adverse childhood experiences-household stressors and children's mental health: a single centre retrospective review.

Authors:  Hilary Holmes; Nicolas Darmanthe; Kevin Tee; Margaret Goodchild
Journal:  BMJ Paediatr Open       Date:  2021-08-17

2.  Trio-based exome sequencing reveals a high rate of the de novo variants in intellectual disability.

Authors:  Alejandro J Brea-Fernández; Miriam Álvarez-Barona; Jorge Amigo; María Tubío-Fungueiriño; Pilar Caamaño; Montserrat Fernández-Prieto; Francisco Barros; Silvia De Rubeis; Joseph Buxbaum; Ángel Carracedo
Journal:  Eur J Hum Genet       Date:  2022-03-23       Impact factor: 5.351

3.  Paediatric genomic testing: Navigating medicare rebatable genomic testing.

Authors:  Rani Sachdev; Mike Field; Gareth S Baynam; John Beilby; Maria Berarducci; Yemima Berman; Tiffany Boughtwood; Marie B Cusack; Vanessa Fitzgerald; Jeffery Fletcher; Mary-Louise Freckmann; Natalie Grainger; Edwin Kirk; Ben Lundie; Sebastian Lunke; Lesley McGregor; David Mowat; Gayathri Parasivam; Vanessa Tyrell; Mathew Wallis; Susan M White; Alan S L Ma
Journal:  J Paediatr Child Health       Date:  2021-02-10       Impact factor: 1.954

4.  A missense mutation in the catalytic domain of O-GlcNAc transferase links perturbations in protein O-GlcNAcylation to X-linked intellectual disability.

Authors:  Veronica M Pravata; Mehmet Gundogdu; Sergio G Bartual; Andrew T Ferenbach; Marios Stavridis; Katrin Õunap; Sander Pajusalu; Riina Žordania; Monica H Wojcik; Daan M F van Aalten
Journal:  FEBS Lett       Date:  2019-11-07       Impact factor: 3.864

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.